[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.120.181. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 314
Citations 0
Health Agencies Update
June 25, 2014

Use of Immunotherapy for Gastrointestinal Cancers

JAMA. 2014;311(24):2473. doi:10.1001/jama.2014.7360

Evidence from a case study of a single patient suggests that an immunotherapy technique may help shrink epithelial cell cancers. The work was funded by the National Cancer Institute.

Malignancies that arise in epithelial cells, such as gastrointestinal cancers, lung cancer, and breast cancer, account for about 90% of US cancer deaths, according to the study’s authors. Using an immunotherapy strategy that has proven effective in treating melanoma, researchers helped boost a patient’s immune response by treating her with T cells targeting mutations in her tumor (Tran E et al. Science. 2014;344[6184]:641-645).

First Page Preview View Large
First page PDF preview
First page PDF preview
×